Zhongzhu Healthcare Holding Co.,Ltd (SHA:600568)
2.210
+0.010 (0.45%)
Aug 20, 2026, 3:00 PM CST
SHA:600568 Revenue
Zhongzhu Healthcare Holding Co.,Ltd had revenue of 108.84M CNY in the quarter ending March 31, 2026, a decrease of -23.06%. This brings the company's revenue in the last twelve months to 544.73M, up 2.23% year-over-year. In the year 2025, Zhongzhu Healthcare Holding Co.,Ltd had annual revenue of 577.34M with 10.73% growth.
Revenue (ttm)
544.73M
Revenue Growth
+2.23%
P/S Ratio
7.83
Revenue / Employee
461.24K
Employees
1,181
Market Cap
4.27B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 577.34M | 55.96M | 10.73% |
| Dec 31, 2024 | 521.39M | -117.18M | -18.35% |
| Dec 31, 2023 | 638.56M | 132.59M | 26.21% |
| Dec 31, 2022 | 505.97M | -75.09M | -12.92% |
| Dec 31, 2021 | 581.06M | -146.41M | -20.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Jianmin Pharmaceutical Group | 3.18B |
| Jinling Pharmaceutical Company | 3.16B |
| Tianjin Lisheng Pharmaceutical | 1.35B |
| Hunan Hansen Pharmaceutical | 1.03B |
| LanZhou Foci Pharmaceutical | 926.49M |
| Qianjiang Yongan Pharmaceutical | 847.91M |
| Sinotherapeutics | 432.19M |